Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
Status:
Completed
Trial end date:
2011-01-25
Target enrollment:
Participant gender:
Summary
Teduglutide is an investigative medicine being evaluated as a possible treatment for people
with parenteral nutrition (PN) dependent Short Bowel Syndrome (SBS). Teduglutide is similar
to a protein the body makes. When people have SBS, their bodies do not make enough of the
protein and they have trouble getting nutrients and fluids from the food they eat and drink.
This study was designed to provide evidence of efficacy, safety, and tolerability of
teduglutide 0.05 mg/kg daily in SBS subjects.